Caldwell Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Caldwell Trust's AMGN Position: Q2 2026 in Review
Caldwell Trust reduced its Amgen (AMGN) stake by 16% in Q2 2026, selling an estimated $1.73M and leaving 26,584 shares worth $9.63M. The position accounts for 0.78% of the portfolio, ranked #37.
Caldwell Trust first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $11.1M in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Caldwell Trust held 26,584 shares of Amgen worth $9.63M as of Q2 2026.
- Caldwell Trust sold 5,047 Amgen shares in Q2 2026, an estimated $1.73M.
- Amgen made up 0.78% of Caldwell Trust's portfolio in Q2 2026, its #37 holding.
- Caldwell Trust first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Caldwell Trust's Amgen position peaked at $11.1M in Q1 2026.
- 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.